AUD 50m? ALA with just 1 or maybe 2 pre-clinicals still at AUD140. In the US, hardly anything sub USD 500m / AUD 750m with similar pipelines, ph 1 data and a CD 17 CAR-T about to go clinical. Using 750m SOI for estimation, 20c would be a MC of just AUD 150m. That would still be just 15-20% of IMU's MC.
Plenty of upside and there is a good chance that CHM overtakes IMU sp-related - hopefully not in a downwards trend as seen before when both traded at about 4c for a very short time.
GLTA
Chimeric: Media Thread, page-651
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.951M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.0¢ | $38.54K | 3.639M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2646760 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 729690 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |